Skip to main content
. 2009 Apr 21;100(10):1540–1548. doi: 10.1038/sj.bjc.6605047

Figure 3.

Figure 3

Overall survival (A) and disease-free survival (B) in curatively treated patients with colorectal cancer in cohort II according to high (n=61) versus low (n=205) TATI best score (cutoff =50% positive cells).